Company profile

Avilar Therapeutics

Pioneering the discovery and development of extracellular protein degraders.

Industry
Biotechnology
Employees
25
Headquarters
Waltham, MA
LinkedIn followers
2,811
Office locations
1

Avilar Therapeutics company summary

Avilar Therapeutics is a company in the Biotechnology industry, headquartered in Waltham, MA. On LinkedIn the company has around 25 employees and 2,811 followers.

What technology does Avilar Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Avilar Therapeutics

Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation. Avilar develops ATACs (ASGPR Targeting Chimeras), a new class of protein degrader therapeutics that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. Avilar has built a proprietary ATAC platform that includes novel, high-affinity, small molecule ASGPR ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of ATAC-mediated endocytosis and degradation. The ATAC platform enables the modular design and synthesis of ATACs extendable across the extracellular proteome to a wide range of proteins involved in the pathogenesis of human diseases. Avilar is leveraging the ATAC platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. Avilar was founded and financed by RA Capital Management and based in Waltham, MA.

Where is Avilar Therapeutics located?

Avilar Therapeutics lists 1 location.

Waltham, MA, USHQ

Compare companies similar to Avilar Therapeutics

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Avilar Therapeutics
avilar-tx.com
Biotechnology25-Waltham, MA
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Avilar Therapeutics

What does Avilar Therapeutics do?

Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation. Avilar develops ATACs (ASGPR Targeting Chimeras), a new class of protein degrader therapeutics that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. Avilar has built a proprietary ATAC platform that includes novel, high-affinity, small molecule ASGPR ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of ATAC-mediated endocytosis and degradation. The ATAC platform enables the modular design and synthesis of ATACs extendable across the extracellular proteome to a wide range of proteins involved in the pathogenesis of human diseases. Avilar is leveraging the ATAC platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. Avilar was founded and financed by RA Capital Management and based in Waltham, MA.

How many employees does Avilar Therapeutics have?

Avilar Therapeutics has around 25 employees on LinkedIn.

Where is Avilar Therapeutics headquartered?

Avilar Therapeutics is headquartered in Waltham, MA.

Build a lead list from companies like Avilar Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.